Related Experiment Video
Updated: Jun 5, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Pertussis epidemic in Korea and implications for epidemic control
1Infectious Disease Control Division, Citizens' Health Bureau, Seoul Metropolitan Government, Seoul, Republic of Korea.
Korea is experiencing an unprecedented pertussis epidemic in 2024, with a notable increase in cases among school-aged children. Further investigation into surveillance and vaccine effectiveness is crucial for understanding this outbreak.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Korea is facing a pertussis (whooping cough) epidemic with record-high incidence rates in 2024.
- The scale of this pertussis increase in Korea is unprecedented compared to global trends.
- A distinctive feature is the high proportion of cases in children aged 5 to 14 years.
Purpose of the Study:
- To analyze the epidemiological trends of the ongoing pertussis epidemic in Korea.
- To highlight the unique characteristics of the 2024 outbreak, particularly the age distribution of cases.
- To emphasize the need for robust surveillance and vaccine evaluation.
Main Methods:
- Epidemiological data analysis of pertussis incidence in Korea.
- Comparative analysis of Korean pertussis trends with global data.
- Assessment of case demographics, focusing on the 5-14 year age group.
Main Results:
- Record-high pertussis incidence observed in Korea.
- The epidemic's scale in Korea is significantly larger and distinct from international patterns.
- Children aged 5 to 14 years represent a disproportionately high percentage of cases.
Conclusions:
- The 2024 pertussis epidemic in Korea requires urgent attention due to its unprecedented scale and affected demographic.
- Accurate interpretation of epidemiological trends necessitates validation of the surveillance system.
- Evaluating the efficacy and effectiveness of pertussis vaccines is essential for control strategies.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Steps in Outbreak Investigation
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...